TY - JOUR
T1 - Urinary albumin/creatinine ratio tertiles predict risk of diabetic retinopathy progression
T2 - a natural history study from the Adolescent Cardio-Renal Intervention Trial (AdDIT) observational cohort
AU - Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)
AU - Benitez-Aguirre, Paul Z.
AU - Marcovecchio, M. Loredana
AU - Chiesa, Scott T.
AU - Craig, Maria E.
AU - Wong, Tien Y.
AU - Davis, Elizabeth A.
AU - Cotterill, Andrew
AU - Couper, Jenny J.
AU - Cameron, Fergus J.
AU - Mahmud, Farid H.
AU - Neil, H. Andrew W.
AU - Jones, Timothy W.
AU - Hodgson, Lauren A.B.
AU - Dalton, R. Neil
AU - Marshall, Sally M.
AU - Deanfield, John
AU - Dunger, David B.
AU - Donaghue, Kim C.
PY - 2022/5
Y1 - 2022/5
N2 - Aims/hypothesis: We hypothesised that adolescents with type 1 diabetes with a urinary albumin/creatinine ratio (ACR) in the upper tertile of the normal range (high ACR) are at greater risk of three-step diabetic retinopathy progression (3DR) independent of glycaemic control. Methods: This was a prospective observational study in 710 normoalbuminuric adolescents with type 1 diabetes from the non-intervention cohorts of the Adolescent Cardio-Renal Intervention Trial (AdDIT). Participants were classified as ‘high ACR’ or ‘low ACR’ (lowest and middle ACR tertiles) using baseline standardised log10 ACR. The primary outcome, 3DR, was determined from centrally graded, standardised two-field retinal photographs. 3DR risk was determined using multivariable Cox regression for the effect of high ACR, with HbA1c, BP, LDL-cholesterol and BMI as covariates; diabetes duration was the time-dependent variable. Results: At baseline mean ± SD age was 14.3 ± 1.6 years and mean ± SD diabetes duration was 7.2 ± 3.3 years. After a median of 3.2 years, 83/710 (12%) had developed 3DR. In multivariable analysis, high ACR (HR 2.1 [1.3, 3.3], p=0.001), higher mean IFCC HbA1c (HR 1.03 [1.01, 1.04], p=0.001) and higher baseline diastolic BP SD score (HR 1.43 [1.08, 1.89], p=0.01) were independently associated with 3DR risk. Conclusions/interpretation: High ACR is associated with greater risk of 3DR in adolescents, providing a target for future intervention studies. Trial registration: isrctn.org ISRCTN91419926. Graphical abstract: [Figure not available: see fulltext.]
AB - Aims/hypothesis: We hypothesised that adolescents with type 1 diabetes with a urinary albumin/creatinine ratio (ACR) in the upper tertile of the normal range (high ACR) are at greater risk of three-step diabetic retinopathy progression (3DR) independent of glycaemic control. Methods: This was a prospective observational study in 710 normoalbuminuric adolescents with type 1 diabetes from the non-intervention cohorts of the Adolescent Cardio-Renal Intervention Trial (AdDIT). Participants were classified as ‘high ACR’ or ‘low ACR’ (lowest and middle ACR tertiles) using baseline standardised log10 ACR. The primary outcome, 3DR, was determined from centrally graded, standardised two-field retinal photographs. 3DR risk was determined using multivariable Cox regression for the effect of high ACR, with HbA1c, BP, LDL-cholesterol and BMI as covariates; diabetes duration was the time-dependent variable. Results: At baseline mean ± SD age was 14.3 ± 1.6 years and mean ± SD diabetes duration was 7.2 ± 3.3 years. After a median of 3.2 years, 83/710 (12%) had developed 3DR. In multivariable analysis, high ACR (HR 2.1 [1.3, 3.3], p=0.001), higher mean IFCC HbA1c (HR 1.03 [1.01, 1.04], p=0.001) and higher baseline diastolic BP SD score (HR 1.43 [1.08, 1.89], p=0.01) were independently associated with 3DR risk. Conclusions/interpretation: High ACR is associated with greater risk of 3DR in adolescents, providing a target for future intervention studies. Trial registration: isrctn.org ISRCTN91419926. Graphical abstract: [Figure not available: see fulltext.]
KW - AdDIT
KW - Adolescents
KW - Diabetic nephropathy
KW - Diabetic retinopathy progression
KW - Kidney function
KW - Microvascular complications
KW - Type 1 diabetes
UR - http://www.scopus.com/inward/record.url?scp=85127395087&partnerID=8YFLogxK
U2 - 10.1007/s00125-022-05661-1
DO - 10.1007/s00125-022-05661-1
M3 - Article
C2 - 35182158
AN - SCOPUS:85127395087
SN - 0012-186X
VL - 65
SP - 872
EP - 878
JO - Diabetologia
JF - Diabetologia
IS - 5
ER -